Personalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Verve Therapeuticsvervetx.com |
Verve Therapeutics is a wholly owned subsidiary of Eli Lilly and Company developing a new class of genetic medicines for cardiovas | Boston, Massachusetts | 51-200 | — |
Arbor Biotechnologiesarbor.bio |
Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, Massachusetts, developing potentially curative | Cambridge, Massachusetts | 51-200 | — |
Beam Therapeuticsbeamtx.com |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Abintusbioabintusbio.com |
Abintus is a biotechnology company pioneering in vivo genetic medicines that engineer cells directly inside the patient's body usi | San Diego, California | 1-10 | — |
Intelliatxintelliatx.com GT |
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severe | Cambridge, Massachusetts | 201-1000 | — |
Metagenomimetagenomi.co |
Metagenomi is a precision genetic medicines company developing curative therapeutics using a proprietary metagenomics-derived geno | Emeryville, California | 51-200 | — |
CRISPR Therapeuticscrisprtx.com |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
Life Edit Inclifeeditinc.com |
Life Edit Inc is a healthcare solutions firm based in Durham, North Carolina, that offers life-changing therapies for genetic diso | Durham, North Carolina | 51-200 | — |
ASC Therapeuticsasctherapeutics.com YY |
ASC Therapeutics is a biotechnology company developing curative gene, CRISPR, and cell therapies for rare diseases, with a pipelin | Milpitas, California | 1-10 | — |
Mammoth Biosciencesmammothbiosci.com |
Mammoth Biosciences is a biotechnology company developing long-term curative therapies using its proprietary ultracompact CRISPR s | South San Francisco, California | 51-200 | — |
| Run live for more | ||||
Verve Therapeutics is a wholly owned subsidiary of Eli Lilly and Company developing a new class of genetic medicines for cardiovascular disease, with lead programs VERVE-102, VERVE-201, and VERVE-301 targeting the three lipoprotein drivers of atherosclerosis.
Companies like Verve Therapeutics include Arbor Biotechnologies, Beam Therapeutics, Abintusbio, Intelliatx, Metagenomi. See the full list of 24 competitors and alternatives above.
Verve Therapeutics has approximately 51-200 employees and is in the Biotechnology Research industry.
Verve Therapeutics is headquartered in Boston, Massachusetts.
Verve Therapeutics operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Verve Therapeutics are listed above, including leaders across executive, finance, sales and operations.